6 Pack: Pfizer, Fauci press forward on 3 additional Omicron-specific mRNA shots

Up the dose.

Make it a six pack.

Pfizer announced Tuesday, to great fanfare from the cattle class, that they are officially starting trials for an Omicron-specific COVID vaccine on their novel mRNA platform.

The projected protocol calls for an additional two dose series followed by a booster some months after the back to back shots. For people who are already triple injected, that can make for 6 shots in total over the course of a couple years, or even sooner, if Pfizer soon receives expedited authorization for its latest formulation. 

Pfizer Inc. @pfizer

As part of ongoing efforts to address #Omicron & determine the potential need for variant-based vaccines, with our partner @BioNTech_Group, we initiated a study evaluating an Omicron-based #COVID19 vaccine candidate in adults 18 through 55. Learn more: on.pfizer.com/3rHh2WA

January 25th 2022

86 Retweets122 Likes

Changing the formula is a newfound endeavor for Pfizer, as the mRNA vaccine developed in collaboration with BioNTech has never been reoriented for any past strains of the coronavirus. Both Pfizer/BioNTech and Moderna that it would be easy to fire up new shots on demand. They have not sufficiently explained why they did not make new shots for previous variants, which were reportedly much more threatening than the Omicron mutation.

Recipients of the current injection continue to receive a shot formulated for the original strain, which has not existed in circulation for a very long time. Additionally, there remains no FDA approved COVID vaccine in the United States.

As I reported previously in The Dossier, The CEO of BioNTech signaled last month that they would move in the direction of a 6 dose mRNA regimen. Today, Pfizer confirmed that they’re moving full steam ahead with the project. 

6 Pack: Pfizer-BioNTech plan another 3 mRNA shots for Omicron

Now in peak COVID/Flu season in much of the world, countries are failing to achieve demonstrable success with the overall mRNA platform. Israel, the most mRNA injected country on earth, where many citizens are now on dose 4 of the original mRNA formula, is currently seeing an unprecedented outbreak of unbelievable proportions. This week, the country is sporting a 20-30% daily positivity rate, with over 500,000 active cases

Covid19Crusher @Covid19Crusher

Eye-popping number of new cases in Israel. We need more time to assess severity trends.

January 25th 2022

111 Retweets274 Likes

Anthony Fauci, the infamous federal bureaucrat and part time Big Pharma used car salesman, was quick to applaud Pfizer for starting the Omicron trials, despite the reality that this new shot will probably not receive clearance until the Omicron wave has completely subsided and there will no longer be any use for the therapy.

Tom Elliott @tomselliott

Dr. Fauci: “Prudent” for @pfizer to be developing an omicron-specific “vaccine”

January 25th 2022

20 Retweets58 Likes

Applauding Pfizer, Anthony Fauci appeared on television Tuesday to rally members of his religious group in support of the company’s press release.

“What the company is trying to do … you’d want to protect people from breakthrough infections and you might want to boost them, it makes sense to think in terms of at least having ready an Omicron-specific boost,” Fauci started. “I think it’s prudent to at least prepare for the possibility that this may be a persistent variant that we have to face,” he added.

Not the best sales job. It seems that even Fauci is having a hard time justifying another monster cash grab for his friends at Pfizer.

Anyway, there you have it. Just 6 shots to stop the spread! 

And to wrap this up, a quick reminder how much the narrative has changed:

Albert Bourla @AlbertBourla

Excited to share that updated analysis from our Phase 3 study with BioNTech also showed that our COVID-19 vaccine was 100% effective in preventing #COVID19 cases in South Africa. 100%! Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline …Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective with 91.3% vaccine efficacy observed against COVID-19, measured seven days through up to six months after the second dose Vaccine was 100% effective in preventing severe disease as defined by the U.S. C…pfizer.com

April 1st 2021

543 Retweets979 Likes

Check out our loyal sponsor:

TrustCapital is the #1 Bitcoin and precious metals IRA/401K platform in America. Sign up using my promo code DOSSIER and you will receive the benefits of tax-free investing and trading with ZERO MONTHLY FEES! Linked here and in the banner.